Preparation and Characterization of Holmium–2-Hydroxypropyl β-Cyclodextrin Inclusion Complex and Its Stability under Gamma Radiation

[1]  J. Nijsen,et al.  The various therapeutic applications of the medical isotope holmium-166: a narrative review , 2019, EJNMMI Radiopharmacy and Chemistry.

[2]  Zhengyang Duan,et al.  Characterization and adsorption properties of cross-linked yeast/β-cyclodextrin polymers for Pb(ii) and Cd(ii) adsorption , 2018, RSC advances.

[3]  O. Tillement,et al.  Synthesis of Highly-loaded Holmium-165 Siloxane Particles for Brachytherapy of Brain Cancer and Injectability Evaluation in Healthy Pig , 2017 .

[4]  Mirla Fiuza Diniz,et al.  Biodegradable seeds of holmium don't change neurological function after implant in brain of rats. , 2017, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[5]  Yu Zhao,et al.  Complexation of Z-ligustilide with hydroxypropyl-β-cyclodextrin to improve stability and oral bioavailability , 2014, Acta pharmaceutica.

[6]  Vesna Nikolić,et al.  Inclusion complexes of sulfanilamide with β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin , 2014, Journal of Inclusion Phenomena and Macrocyclic Chemistry.

[7]  I. Vamvakas,et al.  Radionuclides Used in Nuclear Medicine Therapy – From Production to Dosimetry , 2013 .

[8]  C. Garnero,et al.  Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization. , 2012, Journal of pharmaceutical and biomedical analysis.

[9]  M. Ghannadi‐Maragheh,et al.  Production, Quality Control and Pharmacokinetic Studies of 166Ho-EDTMP for Therapeutic Applications , 2010, Scientia pharmaceutica.

[10]  W. Hennink,et al.  Microspheres with Ultrahigh Holmium Content for Radioablation of Malignancies , 2009, Pharmaceutical Research.

[11]  Wei Wu,et al.  Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique. , 2009, Journal of pharmaceutical sciences.

[12]  Amber Vyas,et al.  Cyclodextrin based novel drug delivery systems , 2008 .

[13]  Thorsteinn Loftsson,et al.  Cyclodextrins as pharmaceutical solubilizers. , 2007, Advanced drug delivery reviews.

[14]  Sung-Joo Hwang,et al.  Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[15]  Dominique Duchêne,et al.  Cyclodextrins and their pharmaceutical applications. , 2007, International journal of pharmaceutics.

[16]  S. Fricker.  The therapeutic application of lanthanides. , 2006, Chemical Society reviews.

[17]  A Atilla Hincal,et al.  Sterile, injectable cyclodextrin nanoparticles: effects of gamma irradiation and autoclaving. , 2006, International journal of pharmaceutics.

[18]  S. Gould,et al.  2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review , 2005 .

[19]  P. V. van Rijk,et al.  Lanthanide bearing microparticulate systems for multi-modality imaging and targeted therapy of cancer. , 2005, Current medicinal chemistry. Anti-cancer agents.

[20]  J. Szejtli.  Introduction and General Overview of Cyclodextrin Chemistry. , 1998, Chemical reviews.

[21]  L. Pannell,et al.  Hydroxypropyl-β-cyclodextrin: preparation and characterization; effects on solubility of drugs , 1986 .

[22]  P. Wolschann,et al.  Cyclodextrin inclusion complexation and pharmaceutical applications , 2020 .

[23]  M. Babu,et al.  Radiopharmaceuticals and their Therapeutic Applications in Health Care System , 2015 .